ML enables more accurate and timely cardiac care decisions and makes scans easier for the patient, says UltraSight CEO Davidi Vortman.  

The American Medical Association today identified the industry giants with the biggest shares of the markets for commercial health insurance, Medicare Advantage, and public health exchanges, with UnitedHealthcare and Elevance Health representing the largest insurers by overall market share. The AMA, which weighs in on policy issues, said high levels of market concentration is leaving […]

The U.S. House of Representatives has passed H.R. 5378, the Lower Costs, More Transparency Act, a bill aimed at mandating greater hospital price transparency that would curb pharmacy benefit manager spread pricing. The bill passed the House by a vote of 320 to 71 and now heads to the Senate for consideration. Congress is scheduled […]

Humana has signaled its intent to reduce its greenhouse gas emissions by 54.6% by 2023, using 2019 as a base year. In line with a 1.5°C temperature trajectory, Humana’s near-term science-based emissions reduction targets have been approved by the Science Based Targets initiative (SBTi).

Researchers at Aalto University in Finland simulate how a single zombie becomes a nationwide apocalypse, says mathematician Pauliina Ilmonen.  

Although the overall implementation of Generative AI in healthcare remains limited, a gradual increase in adoption rates, primarily among larger entities, is starting to take hold, according to a KLAS survey 66 of healthcare executives.   While just a quarter of respondents said they have already incorporated genAI solutions, about six in 10 (58%) expressed […]

AHIP has appointed MIke Tuffin its next president and CEO. Tuffin will officially take the helm of the healthcare payer trade organization effective January 8. He succeeds AHIP CEO Matt Eyles, who decided to step down this year.  Julie Simon Miller, AHIP’s general counsel, has served as interim CEO since September.

Cigna and Humana have reportedly ended their talks to merge after failing to agree on a price, according to Reuters.

Patient advocacy groups have sent a letter to the Centers for Medicare and Medicaid Services criticizing UnitedHealthcare’s Medicare Advantage marketing, asking the agency to investigate potentially misleading advertising tactics.

The White House has signaled its intent to address the potentially negative and problematic aspects of corporate ownership in healthcare, with a focus on drug pricing, transparency and anticompetitive behavior.